Skip to Main Content

Author Details

Sharon E Johnatty
QIMR Berghofer Medical Research Institute
2000
53
24
PMIDPaper TitleJournal TitlePublished Year
37369443Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.Can J Surg2023
35454861CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.Cancers (Basel)2022
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
34245638Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer.Hum Mutat2021
32532784Generating high-quality data abstractions from scanned clinical records: text-mining-assisted extraction of endometrial carcinoma pathology features as proof of principle.BMJ Open2020
32108150Co-existence of leiomyomas, adenomyosis and endometriosis in women with endometrial cancer.Sci Rep2020
32641237Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.Gynecol Oncol2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
29367611Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.Sci Rep2018
30485707Risk and prognostic factors for endometrial carcinoma after diagnosis of breast or Lynch-associated cancers-A population-based analysis.Cancer Med2018
29502561MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.Mayo Clin Proc2018
28050675Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.Cancer Causes Control2017
28486362Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium.Obstet Gynecol2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
29029385Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci.Oncotarget2017
29049607Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.JAMA Oncol2017
28822557Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.Gynecol Oncol2017
27677730No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2017
25940428No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Gynecol Oncol2016
26747452Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2016
26711112Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.Nat Genet2016
26976855Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Cancer Epidemiol Biomarkers Prev2016
26840454Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.Oncotarget2016
26691289Letter to the editor re: "Women with double primary cancers of the colorectum and endometrium: do they have Lynch syndrome?" from T. Song and colleagues.Eur J Obstet Gynecol Reprod Biol2016
26151456Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.Br J Cancer2015
26152742Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.Clin Cancer Res2015
24957074ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.J Natl Cancer Inst2014
25349970Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.Br J Cancer2014
24810093Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer.Sci Rep2014
24740199Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.Cancer Epidemiol Biomarkers Prev2014
24764580Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.Cancer Immunol Res2014
23513043Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.Cancer Epidemiol Biomarkers Prev2013
23917080ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.Gynecol Oncol2013
23845225Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.Lancet Oncol2013
23535731Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nat Genet2013
22274685Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.JAMA2012
22794196Genome-wide association study for ovarian cancer susceptibility using pooled DNA.Twin Res Hum Genet2012
21165769No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women.Breast Cancer Res Treat2011
21949822Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.PLoS One2011
21637745Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.PLoS One2011
21705454Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients.Clin Cancer Res2011
21724856Assessment of hepatocyte growth factor in ovarian cancer mortality.Cancer Epidemiol Biomarkers Prev2011
21385923The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.Clin Cancer Res2011
20628624Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".PLoS Genet2010
18481171The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis.Breast Cancer Res Treat2009
19456219Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.Twin Res Hum Genet2009
19082709No evidence that GATA3 rs570613 SNP modifies breast cancer risk.Breast Cancer Res Treat2009
17592773Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.Breast Cancer Res Treat2008
18765553ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.Clin Cancer Res2008
18431743Consortium analysis of 7 candidate SNPs for ovarian cancer.Int J Cancer2008
  • 1 - 50 of 53

Recommended Authors

Florentine S Hilbers
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 17
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Sander Canisius
The Netherlands Cancer Institute
Career Start Year 2011
Number of shared co-authors 57
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 87
Eric C Polley
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 44
Zhaoming Wang
St Jude Children's Research Hospital
Career Start Year 2007
Number of shared co-authors 90
Claire Palles
Institute of Cancer and Genomic Sciences, University of Birmingham
Career Start Year 2006
Number of shared co-authors 31
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 21
Hisani N Horne
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 29
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 14
Xiaohong R Yang
National Cancer Institute
Career Start Year 2003
Number of shared co-authors 80
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 1
Elad Ziv
Institute for Human Genetics, University of California San Francisco (UCSF)
Career Start Year 2001
Number of shared co-authors 67
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 34
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 17
Sevtap Savas
Memorial University
Career Start Year 1999
Number of shared co-authors 2
Kathryn Alsop
Peter MacCallum Cancer Centre
Career Start Year 1998
Number of shared co-authors 89
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 8
Simone Maistro
Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo
Career Start Year 1994
Number of shared co-authors 0
Matthew L Freedman
Dana-Farber Cancer Institute
Career Start Year 1993
Number of shared co-authors 99
Christine B Ambrosone
Roswell Park Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 110
Meredith Yeager
Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 42
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 71
George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 65
Clare Turnbull
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 80
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 55
Barbara L Weber
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 55
Heather Thorne
Peter MacCallum Cancer Centre
Career Start Year 1982
Number of shared co-authors 83
Daniela Seminara
National Cancer Institute, 9609 Medical Center Dr
Career Start Year 1981
Number of shared co-authors 54
Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1972
Number of shared co-authors 102

Collaborators

Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 38
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 35
Anna DeFazio
Westmead Hospital
Co-authored papers 31
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 28
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 27
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 24
Andrew Berchuck
Duke School of Medicine
Co-authored papers 24
Diether Lambrechts
Co-authored papers 24
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 24
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 23
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 23
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 23
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 22
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 22
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 22
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 21
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 20
Honglin Song
University of Cambridge
Co-authored papers 19
Xiaoqing Chen
QIMR Berghofer Medical Research Institute
Co-authored papers 18
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 18
Anna H Wu
University of Southern California
Co-authored papers 18
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 18
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 17
Tanja Pejovic
Oregon Health & Science University
Co-authored papers 17
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 17
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 17
Alice S Whittemore
Co-authored papers 16
Hoda Anton-Culver
University of California irvine
Co-authored papers 16
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 16
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 16
Release 1.2